aid: pinetree-therapeutics
name: PineTree Therapeutics
description: 'Pinetree Therapeutics, Inc. is a preclinical-stage biotechnology company headquartered
  at West Cambridge Scientific Park, 767C Concord Ave, Cambridge, Massachusetts, developing
  next-generation targeted protein degraders (TPDs) built on its proprietary AbReptor platform. AbReptor
  degrades membrane-bound and extracellular proteins through target co-engagement, induced endocytosis,
  endolysosome formation and lysosomal degradation, aiming to overcome drug resistance and tumor
  recurrence in oncology, with additional application in inflammation and immunology. The company is
  advancing trispecific degraders and ADC-integrated programs, closed a $17M Series A in July 2024, and
  has entered a licensing partnership with AstraZeneca. It is a therapeutics developer rather than a
  software vendor: it publishes no public API, developer portal, SDK or machine-readable specification.'
image: https://www.pinetreetx.com/images/common/logo.png
url: https://raw.githubusercontent.com/api-evangelist/pinetree-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Oncology
- Drug Discovery
- Targeted Protein Degradation
- Preclinical
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/pinetree-therapeutics-domain-security.yml
- type: Website
  url: https://www.pinetreetx.com/
- type: News
  url: https://www.pinetreetx.com/en/news/news.php
- type: Team
  url: https://www.pinetreetx.com/en/team/leadership.php
- type: Careers
  url: https://www.pinetreetx.com/en/careers/job.php
- type: Investors
  url: https://www.pinetreetx.com/en/investors/investors.php
- type: Contact
  url: https://www.pinetreetx.com/en/communication/contact.php
- type: SecondaryMarket
  url: https://forgeglobal.com/pinetree-therapeutics_stock/
- type: LinkedIn
  url: https://www.linkedin.com/company/pinetree-therapeutics
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Pinetree Therapeutics is a preclinical-stage oncology drug developer whose product is a
    protein-degrader therapeutic, not software — its entire public site is seven brochure pages
    (team, science, news, careers, investors, contact) served from PHP with no /developers, /api,
    api./docs./developer. subdomain, sitemap, llms.txt or any /.well-known/ document.
  evidence:
    - url: https://www.pinetreetx.com/
      status: 200
    - url: https://www.pinetreetx.com/developers
      status: 404
    - url: https://www.pinetreetx.com/api
      status: 404
    - url: https://www.pinetreetx.com/openapi.json
      status: 404
    - url: https://www.pinetreetx.com/llms.txt
      status: 404
    - url: https://www.pinetreetx.com/.well-known/agent-card.json
      status: 404
    - url: https://www.pinetreetx.com/.well-known/security.txt
      status: 404
  checked: '2026-08-05'